Aldeyra Therapeutics Inc (ALDX)
SG&A Expenses
$2.37M
Quarterly · Period ending: · USD
ALDX SG&A Expenses
Latest reported$2.37Mperiod ending
Latest reported$2.37Mperiod ending
ALDX Quarterly SG&A Expenses ($20.25K → $2.37M)
Quarterly SG&A Expenses
High-resolution chart · PNG
ALDX sg&a expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expenses (USD) |
|---|---|
| 2,365,993 | |
| 1,137,343,000,000 | |
| 2,364,337 | |
| 2,570,375 | |
| 1,663,503 | |
| 3,004,135 | |
| 1,947,752 | |
| 3,696,067 | |
| 3,038,064 | |
| 3,210,357 | |
| 1,799,496 | |
| 2,588,701 | |
| 3,379,750 | |
| 5,567,416 | |
| 4,735,319 | |
| 3,244,936 | |
| 3,144,280 | |
| 4,249,387 | |
| 2,562,843 | |
| 2,546,807 | |
| 3,068,652 | |
| 3,104,702 | |
| 2,504,993 | |
| 2,255,617 | |
| 2,220,003 | |
| 3,004,841 | |
| 3,213,931 | |
| 2,839,319 | |
| 3,116,414 | |
| 2,985,038 | |
| 2,546,000 | |
| 3,065,912 | |
| 2,373,059 | |
| 1,891,303 | |
| 1,501,246 | |
| 1,475,904 | |
| 1,481,792 | |
| 1,726,878 | |
| 1,205,825 | |
| 1,396,734 | |
| 1,462,227 | |
| 1,455,559 | |
| 1,226,533 | |
| 1,261,196 | |
| 954,879 | |
| 972,101 | |
| 1,007,354 | |
| 772,467 | |
| 982,579 | |
| 800,646 | |
| 832,365 | |
| 500,416 | |
| 660,640 | |
| 141,305 | |
| 20,254 |